UBS Maintains Neutral on Scotts Miracle Gro, Raises Price Target to $70

Benzinga Newsdesk www.benzinga.com Positive 70.9%

Neg 0% Neu 0% Pos 70.9%

UBS analyst Peter Grom maintains Scotts Miracle Gro (NYSE:SMG) with a Neutral and raises the price target from $63 to $70.